Report

Aromatase inhibitors in female breast cancer

Status
Status: Commission completed
Project no.
A10-03
Last updated

Report documents

  1. Executive summary of the final report

    Aromatase inhibitors in female breast cancer

    published on
    Document type
    PDF document, 190 kB, EN, not accessible
  2. Final report

    Aromatase inhibitors in female breast cancer

    published on
    Document type
    PDF document, 4 MB, DE, not accessible
  3. Documentation and evaluation of comments on the preliminary report

    Aromatase inhibitors in female breast cancer

    published on
    Document type
    PDF document, 3 MB, DE, not accessible
  4. Executive summary of the preliminary report

    Aromatase inhibitors in female breast cancer

    published on
    Document type
    PDF document, 194 kB, not accessible
  5. Preliminary report

    Aromatase inhibitors in female breast cancer

    published on
    Document type
    PDF document, 5 MB, not accessible
  6. Report plan version 1.0

    Aromatase inhibitors in female breast cancer

    published on
    Document type
    PDF document, 187 kB, DE, not accessible
  7. Documentation and evaluation of comments on the preliminary report plan

    Aromatase inhibitors in female breast cancer

    published on
    Document type
    PDF document, 2 MB, DE, not accessible
  8. Preliminary report plan

    Aromatase inhibitors in female breast cancer

    published on
    Document type
    PDF document, 171 kB, DE, not accessible

Press releases

Aromatase inhibitors for breast cancer: advantages over tamoxifen in early-stage disease

Longer survival, later recurrences / Evidence for late-stage disease much poorer

Project details

Project no.
A10-03
Commission
Commission awarded on 19.07.2010 by the Federal Joint Committee (GBA).
Report type
Report
Status
Commission completed
Department/Division
Drug Assessment
Topic
Cancer

Contact

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form